Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1850-1856

  Pugin, Jérôme ^a   Ricou, Bara ^b   Steinberg, Kenneth P ^b   Suter, Peter M ^b   Martin, Thomas R ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT;

EID: 0029892565     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665045     Document Type: Article

References (31)

1. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. 1983. Adult respiratory distress syndrome: risk with common predisposition. Ann. Intern. Med. 98:593-597.
2. Matthay, M. A. 1990. The adult respiratory distress syndrome. Definition and diagnosis. Clin. Chest Med. 11:575-580.
3. Steinberg, K. P., J. A. Milberg, T. R. Martin, R. J. Maunder, B. A. Cockrill, and L. D. Hudson. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:113-122.
4. Rinaldo, J. E., and J. W. Christman. 1990. Mechanisms and mediators of the adult respiratory distress syndrome. Clin. Chest Med. 11:621-632.
5. Millar, A. B., M. Singer, A. Meager, N. M. Foley, N. M. Johnson, and G. A. W. Rook. 1989. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet ii:712-714.
6. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
7. Roten, R., M. Markert, F. Feihl, M. D. Schaller, M. C. Tagan, and C. Perret. 1991. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 143:590-592.
8. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J.-M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145:1016-1022.
9. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Wiener-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
10. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647.
11. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
12. Ricou, B., S. Grandin, L. Nicod, J.-B. Thorens, and P. M. Suter. 1995. Adult and paediatric size bronchoscopes for bronchoalveolar lavage in mechanically ventilated patients: yield and side effects. Thorax 50:290-293.
13. Steinberg, K. P., D. R. Mitchell, R. J. Maunder, J. A. Milberg, M. E. Whitcomb, and L. D. Hudson. 1993. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148:556-561.
14. Morel, D. R., F. Dargent, M. Bachmann, P. M. Suter, and A. F. Junod. 1985. Pulmonary extraction of serotonin and propanolol in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:479-484.
15. Crestani, B., P. Cornillet, M. Dehoux, C. Rolland, M. Guenounou, and M. Aubier. 1994. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J. Clin. Invest. 94:731-740.
16. Pugin, J., C.-C. Schürer-Maly, D. Letrucq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. U.S.A. 90:2744-2748.
17. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
18. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchencho, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
19. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 65:55-63.
20. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
21. Reynolds, H. 1987. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135: 250-263.
22. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
23. Nicod, L., B. Galve-de-Rochemonteix, and J. M. Dayer. 1994. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann. N. Y. Acad. Sci. 725:323-330.
24. Meduri, G. U., S. Headley, G. Kohler, F. Stentz, E. Tolley, R. Umberger, and K. Leeper. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062-1073.
25. Takasuka, N., T. Tokunaga, and K. S. Akagawa. 1991. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α but not of IL-1β mRNA. J. Immunol. 146:3824-3830.
26. Jacobs, R. F., D. R. Tabor, A. W. Burks, and G. D. Campbell. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:1686-1692.
27. Arnold, R., B. Humbert, H. Werchau, H. Gallati, and W. König. 1994. Interleukin-8, interleukin-6 and soluble tumour necrosis factor receptor I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126-133.
28. Smith, D. R., S. L. Kunkel, T. J. Standiford, S. W. Chensue, M. W. Rolfe, M. B. Orringer, R. I. Whyte, M. D. Burdick, J. M. Danforth, A. R. Gilbert and R. M. Strieter. 1993. The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am. J. Pathol. 143:794-803.
29. Abdolrasulnia, R., and V. L. Shepherd. 1992. Purification of type I and type II tumor necrosis factor receptors from human lung tissue. Am. J. Respir. Cell Mol. Biol. 7:42-48.
30. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1993. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178:2193-2200.
31. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1995. Tumor necrosis factor-α and interleukin-1β mediate human endothelial cell activation in blood at low endotoxin concentrations. J. Inflamm. 45:49-55.